Who Owns Lucid Diagnostics Stock?
NASDAQ: LUCDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 32.74%
- Held by insiders
- 26.50%
- Institutional holders
- 141
- Institutions 32.7%
- Insiders 26.5%
- Public and other 40.8%
Who owns Lucid Diagnostics stock?
Institutional investors own about 32.7% of Lucid Diagnostics's shares, spread across 141 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 26.50% of LUCD.
The largest institutional holders are Alyeska Investment Group, L.p. (4.36%), Blackrock Inc. (4.12%) and Vanguard Capital Management LLC (3.23%). Together, the top 10 institutions control 23.7% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their LUCD positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LUCD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Alyeska Investment Group, L.p. | 8.86M | 4.36% | +100.0% |
| Blackrock Inc. | 8.37M | 4.12% | +80.5% |
| Vanguard Capital Management LLC | 6.56M | 3.23% | +57.8% |
| Two Seas Capital Lp | 6.00M | 2.95% | 0.0% |
| Masters Capital Management, LLC | 4.00M | 1.97% | 0.0% |
| Aberdeen Group plc | 3.82M | 1.88% | +4.9% |
| Geode Capital Management, LLC | 3.79M | 1.86% | +68.8% |
| State Street Corporation | 2.44M | 1.20% | +56.8% |
| First Manhattan Co. LLC | 2.19M | 1.08% | +576.6% |
| Wells Fargo & Company | 2.07M | 1.02% | +62.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LUCD
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.55M | 2.24% |
| abrdn Healthcare Opportunities Fund | 3.82M | 1.88% |
| iShares Trust-iShares Russell 2000 ETF | 3.51M | 1.73% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.86M | 0.92% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.58M | 0.78% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.41M | 0.69% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 790.27K | 0.39% |
| iShares Trust-iShares Micro-Cap ETF | 509.40K | 0.25% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 459.88K | 0.23% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 362.86K | 0.18% |
Frequently asked questions
Who is the largest shareholder of Lucid Diagnostics?
Alyeska Investment Group, L.p. is the largest institutional shareholder of LUCD, owning 4.36% of shares outstanding (8.86M shares) as of its latest 13F filing.
What percentage of Lucid Diagnostics is owned by institutions?
Institutions own about 32.7% of LUCD shares and 44.6% of the public float.
How much of Lucid Diagnostics do insiders own?
Insiders, such as officers and directors, own about 26.50% of LUCD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.